Thanks for the shout-out BBNCT. Yes, the situation there seems to be growing more dire by the day. Communication with my contacts in the medical field have been much less frequent since the FDA letter (unsurprisingly) and like-wise; I have not tried to rock the boat.
As of June, there was still plenty of leronlimab dispersed throughout the hospitals and doctors would treat any severe or critical patient who could prove they have the means to pay for the drug. I'll repeat the info here from my last post that details a recent successfully treated case in June from my last correspondance:
A younger person in their 20's suffered with a severe case of COVID and overwhelming cytokine storm reaction at home for 3 weeks before being hospitalized with hypoxemia. At hospitalization, their blood oxygen levels were as low as 72-73.
The patient was given oxygen support and 3 doses of Leronlimab. Dramatic improvement was seen on week 1 with oxygen levels back in the low 90s and sustainable improvement in recovery was observed in the following 2 weeks of treatment. They were kept in the hospital for an additional week for observation and later released after 4 weeks total in the hospital. Blood work was also taken for bio-marker analysis during treatment periods.
The drug works without a doubt. I'll reach out again and see what falls from the tree over the next couple of days.
News 
Market Data 
Discover 
